Compare ANNX & TK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANNX | TK |
|---|---|---|
| Founded | 2011 | 1973 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 812.7M | 925.8M |
| IPO Year | 2020 | 1995 |
| Metric | ANNX | TK |
|---|---|---|
| Price | $5.39 | $11.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 553.1K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 15.21% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16,320.74 | N/A |
| P/E Ratio | ★ N/A | $13.43 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $7.12 |
| 52 Week High | $7.18 | $14.38 |
| Indicator | ANNX | TK |
|---|---|---|
| Relative Strength Index (RSI) | 47.18 | 52.05 |
| Support Level | $4.66 | $11.25 |
| Resistance Level | $5.65 | $12.50 |
| Average True Range (ATR) | 0.55 | 0.39 |
| MACD | -0.04 | 0.10 |
| Stochastic Oscillator | 28.70 | 97.43 |
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.